Tag Archives: dual antiplatelet therapy (DAPT)

Introduction Dual antiplatelet therapy (DAPT) comprises a combination of aspirin and thienopyridine agents, such as clopidogrel, prasugrel and ticagrelor. DAPT is the cornerstone of treatment of patients presenting with acute coronary syndrome (ACS), undergoing either medical therapy alone or percutaneous coronary intervention (PCI).1,2 There has been considerable progress in the treatment of ACS with the advent of more potent agents, in addition to therapeutic anticoagulation. DAPT has contributed to improved outcomes in patients presenting with ACS, with numerous studies showing a marked reduction in major adverse cardiovascular and cerebr